SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Culper Researchs short report alleging Cerebras wafer-scale chips may have short field lives and costly power and reliability issues is driving bearish attention and selling; the claims remain disputed. Bulls call the report self-interested and point to Oracles planned cloud integration, while others worry about upcoming insider share unlocks and the companys valuation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reached its prespecified 80th event, triggering final analysis and setting up preliminary GPS overall-survival results expected this quarter. The milestone was followed by a sharp selloff, with traders divided between viewing it as a sell-the-news reaction ahead of a binary readout and seeing the lengthy trial duration as an encouraging but unconfirmed efficacy signal.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention as shares hit fresh lows, with traders focusing on the prolonged selloff and questioning the companys weak business fundamentals, dilution and reliance on Trump. Bearish posts dominate, while some holders argue the decline may set up a rebound or future merger-related catalyst; political uncertainty is also a recurring concern.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

A Trian-led groups proposed take-private bid has driven attention to Wendys, but it is an offer rather than a completed deal. Traders are divided over whether the bid undervalues the company and may be raised or countered, while others see it as a potential floor and speculate about short covering.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims is drawing attention over reports that the U.S. may temporarily ease restrictions on compounding certain peptides, which traders see as a potential new product opportunity. The community is split between optimism about the market potential and frustration that the shares have moved modestly, with some expecting a sell-the-news pullback amid persistent trading-range and short-interest chatter.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

A Q3 earnings miss and much weaker-than-expected Q4 outlook, amid soft residential solar demand pressured by high interest rates and expiring tax credits, drove a sharp selloff and analyst downgrades. Traders are split between expecting further downside and buying the dip, with some pointing to Enphases AI data-center transformer opportunity as a longer-term prospect while noting it remains years away.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

Attention centers on ServiceNows quarterly earnings and guidance, especially subscription and cRPO growth and whether AI products can translate into recurring revenue. Bulls point to enterprise AI adoption and the companys core business, while skeptics cite high expectations, past post-earnings declines, and recent share-price volatility.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

Record quarterly results, strong AI-memory demand, and expectations that supply will remain tight are driving SKHYs rally; traders also point to the companys shareholder-return plans. The reaction is broadly bullish, though some question the ADRs premium and warn that memory remains a cyclical business with potential for a post-earnings pullback.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientifics lowered full-year outlook and forecast for a fourth-quarter sales decline, with the company citing lingering effects from a cybersecurity disruption, are driving attention after its latest report. Traders are split between criticizing management and fearing a deeper slowdown, and viewing the selloff as excessive given that quarterly sales topped estimates.

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

Genmab - ADR

Genmabs Phase 3 head-and-neck cancer trial of petosemtamab plus Keytruda met both primary endpoints and showed a substantial survival benefit versus Keytruda alone, driving a sharp rally and fresh highs. Traders are broadly upbeat on the clinical data, while some caution that the move may reflect pipeline euphoria and raise valuation concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


dagatructiepthomobiz

ĐÁ GÀ TRỰC TIẾP THOMO